港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

海西新藥

180.100

+20.10012.56%

成交量：176.79萬

成交額：3.12億

市值：141.75億

市盈率：88.95

高：184.000

開：163.200

低：163.000

收：160.000

52周最高：184.000

52周最低：97.500

股本：7,870.73萬

香港流通股本：7,870.73萬

量比：3.88

換手率：2.25%

股息：- -

股息率：- -

每股收益(LYR):2.025

淨資產收益率：28.75%

總資產收益率：12.62%

市淨率：22.97

市盈率(LYR):88.95

市銷率: 26.64

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

創新藥概念股強勢走高樂普生物-B(02157)漲14.79% 機構指板塊迎來多重共振

港股異動 | 海西新藥(02637)績後升逾8% 25年度淨利按年增超三成海慧通新入選國家VBP計劃規格

海西新藥(02637)公布2025年業績淨利約1.77億元按年增長30.09%

海西新藥2025年營收5.82億元按年增長逾兩成

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02637"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"海西新藥","latestPrice":180.1,"timestamp":1775030909286,"preClose":160,"halted":0,"volume":1767900,"delay":0,"changeRate":0.12562499999999996,"floatShares":78707270,"shares":78707270,"eps":2.024774,"marketStatus":"已收盤","change":20.1,"latestTime":"04-01 16:08:29","open":163.2,"high":184,"low":163,"amount":311703200,"amplitude":0.13125,"askPrice":180.3,"askSize":300,"bidPrice":180.1,"bidSize":100,"shortable":0,"etf":0,"ttmEps":2.49,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1775093400000},"marketStatusCode":5,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":160,"openAndCloseTimeList":[[1775007000000,1775016000000],[1775019600000,1775030400000]],"volumeRatio":3.875019,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"12.62%","roe":"28.75%","lyrEps":2.024774,"volumeRatio":3.875019,"shares":78707270,"dividePrice":0,"high":184,"amplitude":0.13125,"preClose":160,"low":163,"week52Low":97.5,"pbRate":"22.97","psRate":"26.64","week52High":184,"institutionHeld":0,"latestPrice":180.1,"committee":-0.5,"eps":2.024774,"divideRate":0,"volume":1767900,"delay":0,"ttmEps":2.49,"open":163.2,"prevYearClose":136,"prevWeekClose":154.2,"prevMonthClose":160,"prevQuarterClose":160,"fiveDayClose":147.5,"twentyDayClose":137.7,"sixtyDayClose":131.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2026-03-31","current":72.329317,"percent":0.963636,"low":41.43616,"twenty":67.33509,"median":69.756887,"eighty":74.149597,"high":84.764482,"avg":70.149276,"sd":6.39623,"marketCap":12593163200},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640},{"date":"2025-11-21","current":66.575785,"twenty":58.2567,"median":64.026746,"eighty":69.208194,"marketCap":9917116020},{"date":"2025-11-28","current":68.072175,"twenty":59.478322,"median":65.807152,"eighty":68.767812,"marketCap":10176850011},{"date":"2025-12-05","current":68.42835,"twenty":59.854834,"median":66.893861,"eighty":68.767812,"marketCap":10247686554},{"date":"2025-12-12","current":69.403659,"twenty":60.326406,"median":67.279459,"eighty":69.361692,"marketCap":10412971821},{"date":"2025-12-19","current":69.502155,"twenty":61.237436,"median":67.861589,"eighty":69.423358,"marketCap":10452325456},{"date":"2025-12-24","current":72.521094,"twenty":61.537644,"median":68.055113,"eighty":69.462757,"marketCap":10940310530},{"date":"2026-01-02","current":68.547,"twenty":62.032842,"median":68.254334,"eighty":69.697511,"marketCap":10381488913},{"date":"2026-01-09","current":76.256401,"twenty":63.533346,"median":68.54394,"eighty":70.33117,"marketCap":11577839417},{"date":"2026-01-16","current":83.450154,"twenty":64.030428,"median":68.594109,"eighty":71.180851,"marketCap":12711224105},{"date":"2026-01-23","current":75.203122,"twenty":64.243828,"median":68.851274,"eighty":73.407226,"marketCap":11444037058},{"date":"2026-01-30","current":72.029156,"twenty":65.345972,"median":69.26967,"eighty":73.580372,"marketCap":11011147073},{"date":"2026-02-06","current":69.741329,"twenty":66.631937,"median":69.18814,"eighty":73.524909,"marketCap":10688447266},{"date":"2026-02-13","current":69.700471,"twenty":66.864009,"median":69.376262,"eighty":73.289662,"marketCap":10743542355},{"date":"2026-02-20","current":69.085102,"twenty":66.878935,"median":69.376262,"eighty":72.984771,"marketCap":10633352177},{"date":"2026-02-27","current":72.331605,"twenty":67.046254,"median":69.403659,"eighty":72.584608,"marketCap":11255139610},{"date":"2026-03-06","current":63.89376,"twenty":67.046254,"median":69.448144,"eighty":72.584608,"marketCap":9862020931},{"date":"2026-03-13","current":75.4784,"twenty":67.193436,"median":69.633279,"eighty":73.562991,"marketCap":11703771049},{"date":"2026-03-20","current":69.956787,"twenty":67.26348,"median":69.715081,"eighty":73.483508,"marketCap":10806508171},{"date":"2026-03-27","current":78.768036,"twenty":67.31702,"median":69.741329,"eighty":73.616705,"marketCap":12136661034},{"date":"2026-03-31","current":81.416102,"twenty":67.33509,"median":69.756887,"eighty":74.149597,"marketCap":12593163200}],"updateTime":1775034947102},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02637\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624833564","title":"創新藥概念股強勢走高 樂普生物-B(02157)漲14.79% 機構指板塊迎來多重共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2624833564","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624833564?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 13:19","pubTimestamp":1775020740,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念股强势走高，乐普生物-B 涨14.79%，荣昌生物涨14.41%，欧康维视生物-B涨14.25%，亚盛医药-B涨12.07%，博安生物涨11.41%，诺诚健华涨11.21%，海西新药涨11.19%，三生制药涨10.78%，康诺亚-B涨10.21%。华鑫证券表示，2026年中国创新出海趋势持续强化，同时市场对创新药配置有望回升，维持医药行业“推荐”的评级。创新药迎来重要配置机遇，看好目前处于领先位置的双抗和多抗组合。期待今年年4-6月重磅学术会议带来的中国创新药企重磅研究。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978033","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","LU1969619763.USD","01530","09969","09995","06855","06955","02157","02637","159992","BK1583","BK1161","02162","LU2328871848.SGD","HK0000165453.HKD","BK1191","BK1593","01477","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568490","title":"港股異動 | 海西新藥(02637)績後升逾8% 25年度淨利按年增超三成 海慧通新入選國家VBP計劃規格","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568490","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624568490?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 10:13","pubTimestamp":1775009626,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海西新药(02637)绩后涨超8%，截至发稿，涨8.06%，报172.9港元，成交额6217.15万港元。消息面上，3月31日，海西新药公布2025年业绩，收益为约5.82亿元，同比增长24.79%；净利约1.77亿元，同比增长30.09%；每股盈利为2.55元。公告称，收益增加主要归因于集团年内增强营销力度，带动海慧通®及安必力®的销售收入增长。特别是，海慧通®于2025年新入选国家VBP计划规格(5mg/20mg×14片)，有效推动医院渠道拓展及终端市场销售增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637","VXUS","BK1191","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623347378","title":"海西新藥(02637)公布2025年業績 淨利約1.77億元 按年增長30.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623347378","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623347378?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 00:17","pubTimestamp":1774887449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海西新药(02637)公布2025年业绩，收益为约5.82亿元，同比增长24.79%;净利约1.77亿元，同比增长30.09%;每股盈利为2.55元。公告称，收益增加主要归因于集团年内增强营销力度，带动海慧通®及安必力®的销售收入增长。特别是，海慧通®于2025年新入选国家VBP计划规格(5mg/20mg×14片)，有效推动医院渠道拓展及终端市场销售增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海西新药(02637)公布2025年业绩 净利约1.77亿元 同比增长30.09%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192657544","title":"海西新藥2025年營收5.82億元 按年增長逾兩成","url":"https://stock-news.laohu8.com/highlight/detail?id=1192657544","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192657544?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 22:39","pubTimestamp":1774881583,"startTime":"0","endTime":"0","summary":"海西新药截至2025年12月31日止财政年度录得收益人民币5.82亿元，较2024年的4.67亿元上升24.79%。同期内，净利润为1.77亿元，较上年度的1.36亿元增长30.09%，每股盈利由人民币2.02元增加至人民币2.55元。公司指，收入主要来自14种已获批准药品销售，报告期内药品销售收入为5.81亿元，服务收入为130.30万元。至2025年年底，已动用约74.66百万元人民币款项，主要用于创新药临床试验及产品组合拓展、生产系统及商业化能力提升，以及一般营运资金。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":20,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02637\",params:#limit:6,delay:false,,,undefined,":[]}}